The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Alternative bowel preps prove useful for CT colonography
November 27th 2006Noncathartic bowel preparation is not an obstacle to accurate CT colonography (CTC). Preparations such as fecal tagging, electronic cleansing, and the use of stool-subtraction algorithms produce results comparable to those obtained with conventional bowel-cleansing preparations, according to studies presented at the 2006 RSNA meeting.
MR colonography proves effective, but no more palatable to patients
November 27th 2006Although MR colonography (MRC) is proving to be an effective method of colorectal screening, patients are no more likely to accept it than optical colonoscopy, according to two studies presented at the RSNA meeting.
Alternative bowel preps prove useful for CT colonography
November 27th 2006Noncathartic bowel preparation is not an obstacle to accurate CT colonography (CTC). Preparations such as fecal tagging, electronic cleansing, and the use of stool-subtraction algorithms produce results comparable to those obtained with conventional bowel-cleansing preparations, according to studies presented at the RSNA meeting on Monday.
ScImage readies next-generation PACS
November 26th 2006IT specialist ScImage debuted a multidepartment PACS, Version 3.0 PicomEnterprise, at the 2006 RSNA meeting. The PACS uses a single database, which allows exams to be scheduled, tracked, reported, archived, and distributed across radiology, cardiology, nuclear medicine, and orthopedics using one Web-based log-on.
PET/CT colonography outperforms CT colonography for tumor staging
November 26th 2006The assumption that CT colonography is the logical choice for pairing with optical colonoscopy to stage colorectal cancer took a hit at the RSNA meeting today. A prospective study from Europe shows that whole-body FDG-PET/CT is significantly more accurate than CT colonography for staging colorectal tumors.
GE allies with healthcare providers to develop CT colonography
November 22nd 2006GE Healthcare will sign today an agreement with the Cleveland Clinic and outpatient provider AmSurg to explore how CT colonography might evolve into an accepted screening tool for colon cancer. The agreement calls for GE to provide equipment, engineering, and support; eRadiology, the teleradiology group within the Cleveland Clinic radiology division, will provide clinical expertise; and AmSurg will provide the outpatient facilities for conducting CTC exams.
Nuclear medicine techs love job but see changes coming
November 21st 2006Nuclear medicine technologists enjoy their jobs and find their salaries near the top of the scale for professions with similar educational requirements. They are concerned, however, about changes being wrought by new imaging technology and practice patterns, according to a survey sponsored by the Society of Nuclear Medicine Technologists Section.
Holiday travel can ring more than jingle bells
November 15th 2006The Society of Nuclear Medicine wants healthcare providers to inform patients undergoing nuclear medicine treatment or testing that they may set off security alarms at high-risk locations with the radioactive materials in their bodies.
FDA reviewers stay red hot in September
November 9th 2006The imaging industry tallied another 34 FDA clearances in September, pushing the running count for the year to 261. Image management led all categories with 14 devices, followed by x-ray with 10, radiotherapy with four, ultrasound and CT each with two, and nuclear medicine with one. A surgical microscope accessory that is used to view intraoperative cerebral blood flow fits none of the traditional categories.
3D display creates stereoscopic images without glasses
November 1st 2006Siemens Medical Solutions will spotlight a new kind of medical display at the upcoming RSNA meeting, one that creates volumetric images that appear to hang in space beyond the flat screen of the monitor. Unlike similar systems that have popped up in the past, however, this display will not require the user to wear glasses.
Incidental findings raise costs of CT colonography
October 27th 2006Virtual colonoscopy finds anomalies outside the colon that require additional tests though they often present no risk to patients. These tests unnecessarily raise the overall cost of healthcare, making CT colonography more expensive than the traditional procedure, according to a study conducted by Dr. Richard S. Bloomfeld, an assistant professor of medicine at Wake Forest University Baptist Medical Center.
Philips gets FDA OK to market advanced gamma camera
October 20th 2006Philips Medical Systems gained 510(k) clearance in August to market a nuclear medicine camera that promises to overshadow the company’s high-performance Forte gamma camera. Philips declined to be interviewed about the new system, but the FDA document provides a detailed description.